Management of Hematuria in a 52-Year-Old Woman on Ciprofloxacin
Stop ciprofloxacin immediately and obtain urine culture with susceptibilities to guide alternative antibiotic therapy, as ciprofloxacin is a rare but documented cause of drug-induced hematuria and more serious hematologic complications.
Clinical Assessment
This patient presents with hematuria while on ciprofloxacin for a presumed urinary tract infection (UTI), with laboratory findings showing:
- Leukocytosis (WBC 13.3 × 10⁹/L) with neutrophilia (10.1 × 10⁹/L)
- Normal comprehensive metabolic panel (ruling out acute kidney injury)
- Positive urinalysis
The elevated WBC with neutrophilia suggests either ongoing infection or a systemic inflammatory response 1. The normal renal function is reassuring but doesn't exclude drug-induced urologic complications.
Immediate Actions
1. Discontinue Ciprofloxacin
Ciprofloxacin has been directly associated with hematuria in case reports 2, and more seriously, with hemolytic-uremic syndrome (HUS) 3 and thrombotic thrombocytopenic purpura (TTP) 4. While rare, these are life-threatening complications that present with hematuria, thrombocytopenia, and microangiopathic hemolytic anemia. The FDA drug label for ciprofloxacin notes that crystalluria can occur, particularly in alkaline urine, which may contribute to hematuria 5.
2. Obtain Urine Culture Before Switching Antibiotics
A urine culture and susceptibility testing must be performed before initiating alternative therapy 6, 7. This is critical for:
- Confirming bacterial UTI versus other causes of hematuria
- Identifying the causative organism
- Guiding appropriate antibiotic selection based on susceptibilities
3. Rule Out Serious Hematologic Complications
Check immediately:
- Complete blood count with peripheral smear (looking for schistocytes, thrombocytopenia)
- Lactate dehydrogenase (LDH)
- Haptoglobin
- Direct Coombs test
If schistocytes are present with thrombocytopenia and elevated LDH, this suggests TTP/HUS and requires urgent hematology consultation and plasmapheresis 3, 4.
Antibiotic Management
Determine Infection Severity
For uncomplicated cystitis (if no fever, flank pain, or systemic symptoms):
- First-line alternatives include nitrofurantoin (100 mg twice daily for 5-7 days) or trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) if local resistance is <20% 6
- Fosfomycin (3g single dose) is another option 6
For pyelonephritis (if fever, flank pain, or systemic symptoms present): Given the leukocytosis and neutrophilia, consider pyelonephritis. The patient requires:
- If fluoroquinolone resistance is <10% locally: Switch to oral levofloxacin 750 mg daily for 5 days OR continue ciprofloxacin only if culture confirms susceptibility and hematuria resolves after stopping initial course 6, 7, 6
- If fluoroquinolone resistance is >10% or unknown: Administer one-time IV dose of ceftriaxone 1g, then oral cefpodoxime 200 mg twice daily for 10 days 6, 7, 6
- If organism susceptibility is known: Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days is appropriate if susceptible 6
Important Caveat About Fluoroquinolones
While fluoroquinolones (including ciprofloxacin) are highly effective for UTIs 6, 7, guidelines recommend reserving them for more serious infections due to collateral damage (resistance development) and adverse effects 6. In this case, the temporal association between ciprofloxacin use and hematuria development makes continuing any fluoroquinolone inadvisable unless absolutely necessary based on culture results.
Additional Evaluation for Hematuria
Hydration Status
Ensure adequate hydration to prevent crystalluria, which can occur with ciprofloxacin and other antibiotics 5. The patient should maintain urine output >1.5 liters daily.
Imaging Considerations
If hematuria persists after stopping ciprofloxacin and treating the infection:
- Obtain renal ultrasound to evaluate for obstruction, stones, or structural abnormalities 7, 8
- Consider CT urography if risk factors for malignancy exist (age >35, smoking history, gross hematuria) 8
Cystoscopy
Gross hematuria in a 52-year-old woman warrants cystoscopy evaluation, particularly if hematuria persists after infection treatment, as malignancy risk is 2.6-4% in microhematuria and up to 30-40% in gross hematuria 8.
Monitoring
- Repeat urinalysis 48-72 hours after stopping ciprofloxacin to assess hematuria resolution
- Repeat CBC to ensure WBC normalizes with appropriate antibiotic therapy
- If hematuria persists beyond infection treatment, proceed with urologic evaluation including imaging and cystoscopy 8
Common Pitfalls to Avoid
- Don't continue ciprofloxacin without culture confirmation - The temporal relationship between drug initiation and hematuria development suggests drug causation
- Don't assume all hematuria is from infection - While UTI is likely given the positive UA and leukocytosis, drug-induced causes and underlying urologic pathology must be excluded
- Don't delay culture collection - Obtain culture before switching antibiotics to guide definitive therapy 6, 7
- Don't miss TTP/HUS - Check for thrombocytopenia and hemolysis, as these are medical emergencies requiring immediate intervention 3, 4